Additional Fed rate cuts will boost confidence in one overlooked area of the market, a Goldman Sachs portfolio manager said.

Goldman Sachs Group Inc. is betting the pound will be one of the biggest beneficiaries of prolonged weakness in the dollar ...

Goldman Sachs downgraded Azul S.A. (NYSE:AZUL) to a Neutral rating after having the airline stock slotted at Buy. The firm ...

LONDON (Reuters) - Hedge funds bought U.S. tech and media stocks at the fastest pace in four months last week, said a Goldman ...

Tarajano, Goldman Sachs Private Wealth global head of capital markets, joins CNBC's 'Closing Bell' to discuss reactions to ...

周二，CFRA将Goldman Sachs (NYSE:GS)股票评级从买入上调至强烈买入，并将目标价从之前的540美元上调至553美元。该金融研究公司表示，股价近期的下跌和潜在的盈利增长是此次上调的基础。 CFRA分析师维持了Goldman ...

News of Goldman’s $400 million projected loss caused shares to decline 4% but the stock has since rebounded, adding nearly 4% ...

Having examined the options trading patterns of Goldman Sachs Gr, our attention now turns directly to the company. This shift ...

Goldman Sachs and Fortress Investment Group are among those launching REITs to seize on the changing debt environment, ...

Goldman Sachs reiterated its optimistic outlook on gold prices on Monday, citing central bank demand and the imminent ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber ...

Goldman Sachs周一重申了对CG Oncology (NASDAQ:CGON)股票的买入评级，目标价维持在52.00美元。这一评估是在Johnson & Johnson在2024年欧洲医学肿瘤学会(ESMO)会议上发布TAR-200(单独使用或与cetrelimab联合使用)治疗BCG无反应性非肌层浸润性膀胱癌(NMIBC)患者的SunRISe-1第三期研究新数据之后做出的。 最新研究结 ...